Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketotifen cream for eczema
IRCT20250122064483N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketotifen and corticosteroids in atopic dermatitis (AD) (3 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Change in eczema skin signs and symptoms after 2 months. Started Mar 2025; status: completed.
02
Drugs
ketotifencorticosteroids
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on IRCT20250122064483N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250122064483N1.